Oxford University Press's
Academic Insights for the Thinking World

  • Author: Kiashini Sriharan

New NHS treatments: a real breakthrough for breast cancer?

In November last year, after much debate over cost, the National Institute for Health and Care Excellence (NICE) approved two new drugs for treatment of breast cancer for use on the NHS. Although first approval happened some time ago, this decision to make palbociclib and ribociclib available on the NHS, gives thousands more people access.

Read More